Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19 Infection
100%
Acute Posterior multifocal Placoid pigment Epitheliopathy
100%
Relentless Placoid Chorioretinitis
50%
Adalimumab
25%
High Risk
12%
Inflammatory Activity
12%
Symptom Onset
12%
Ocular Manifestations
12%
Clinical Features
12%
Prednisolone
12%
Visual Loss
12%
Fluorescein Angiography
12%
Polymerase Chain Reaction Assay
12%
Severely Affected
12%
Young Males
12%
Biological Therapy
12%
Immunosuppressive Therapy
12%
Posterior Pole
12%
Active Inflammation
12%
Oral Prednisolone
12%
New Lesion
12%
Eye Disorders
12%
Fundoscopy
12%
Visual Symptoms
12%
Visual Disability
12%
Aberrant Response
12%
Progressive Conditions
12%
Optical Coherence Tomography Angiography (OCT-A)
12%
COVID-19
12%
Patients with COVID-19
12%
SARS-CoV-2 Infection
12%
Inflammatory Chorioretinopathy
12%
Retinal Periphery
12%
Steroid Taper
12%
Serpiginous Choroiditis
12%
Long-lasting Activity
12%
Placoid Lesion
12%
Visual Recovery
12%
Medicine and Dentistry
Infection
100%
COVID-19
100%
Acute Posterior Multifocal Placoid Pigment Epitheliopathy
100%
Chorioretinitis
62%
Symptom
25%
Adalimumab
25%
Prednisolone
25%
Immunosuppressive Treatment
12%
Visual Impairment
12%
Ophthalmoscopy
12%
Fluorescein Angiography
12%
Polymerase Chain Reaction
12%
Biological Therapy
12%
Clinical Feature
12%
Posterior Pole
12%
Clinical Finding
12%
Eye Disease
12%
Chorioretinopathy
12%
Optical Coherence Tomography Angiography
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%